GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vapotherm Inc (OTCPK:VAPO) » Definitions » Net Income

Vapotherm (Vapotherm) Net Income : $-58.19 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Vapotherm Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Vapotherm's Net Income for the three months ended in Dec. 2023 was $-10.19 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was $-58.19 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Vapotherm's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $-1.60.


Vapotherm Net Income Historical Data

The historical data trend for Vapotherm's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vapotherm Net Income Chart

Vapotherm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income
Get a 7-Day Free Trial -51.06 -51.50 -59.80 -113.26 -58.19

Vapotherm Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.44 -18.09 -14.79 -15.13 -10.19

Vapotherm Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Vapotherm's Net Income for the fiscal year that ended in Dec. 2023 is calculated as

Net Income(A: Dec. 2023 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-58.067+-0.126+0+0
=-58.19

Vapotherm's Net Income for the quarter that ended in Dec. 2023 is calculated as

Net Income(Q: Dec. 2023 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-10.111+-0.074+0+0
=-10.19

Net Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-58.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vapotherm  (OTCPK:VAPO) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Vapotherm's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Vapotherm Net Income Related Terms

Thank you for viewing the detailed overview of Vapotherm's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Vapotherm (Vapotherm) Business Description

Traded in Other Exchanges
N/A
Address
100 Domain Drive, Exeter, NH, USA, 03833
Vapotherm Inc is a medical technology company based in the United States. It is mainly engaged in the development and commercialization of its proprietary Hi-VNI technology products that are used to treat patients of all ages suffering from respiratory distress. The company offers four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox. It generates revenue primarily from sales of proprietary Precision Flow systems to hospitals through a direct sales organization in the United States and distributors in select countries outside of the United States.
Executives
Joseph Army director, officer: President and CEO ONE WASHINGTON CENTER, SUITE 400, DOVER NH 03820
Anthony L. Arnerich director 100 DOMAIN DRIVE, EXETER NH 03833
Dorota Mckay officer: Chief Accounting Officer 100 DOMAIN DRIVE, EXETER NH 03833
John Landry officer: See Remarks 100 DOMAIN DRIVE, EXETER NH 03833
James W Liken director 5 DEER SPRING LANE, PITTSBURGH PA 15211
Lance A Berry director 5677 AIRLINE ROAD, ARLINGTON TN 38002
Elizabeth H Weatherman director C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Richard R Barrera 10 percent owner 767 THIRD AVENUE, 29TH FLOOR, NEW YORK NY 10017
Roystone Capital Holdings Llc 10 percent owner 767 THIRD AVENUE, 29TH FLOOR, NEW YORK NY 10017
Roystone Capital Management Lp 10 percent owner 780 THIRD AVENUE, 41ST FLOOR, NEW YORK NY 10017
Brian Lawrence officer: SVP & Chief Technology Officer 100 DOMAIN DRIVE, EXETER NH 03833
Prescott General Partners Llc 10 percent owner, other: Member of Section 13(d) Group 2200 BUTTS ROAD, SUITE 320, BOCA RATON FL 33431
Gregoire Ramade officer: Vice President, International 100 DOMAIN DRIVE, EXETER NH 03833
Joel F. Dube officer: Chief Accounting Officer 100 DOMAIN DRIVE, EXETER NH 03833
Donald J Spence director C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304